House Passes Opioid Package, Concluding Two-week Focus on Issue

Jun 22, 2018 - 02:41 PM
opioid-legislation

The House of Representatives today voted 396-14 to approve bipartisan legislation (H.R. 6) that will serve as a Senate vehicle for many of the House-passed bills to combat the opioid crisis and includes a number of AHA-supported provisions. 

“America’s hospitals and health systems applaud today’s House passage of several AHA-supported provisions contained in the bipartisan Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (H.R. 6),” said AHA Executive Vice President Tom Nickels. “We are pleased to see overwhelming support for provisions that would: expand the use of telehealth services for substance use disorder; guide improved care for infants with neonatal abstinence syndrome; increase the types and capacity of providers offering medication-assisted treatment; cover screening for opioid use disorder as part of the Welcome to Medicare physical examination; allow former foster children to keep Medicaid coverage until age 26 when they move across state lines; and, require states to automatically restore Medicaid coverage to young people post-incarceration. We look forward to continuing to work with the Senate to enact these provisions and further refine other elements of opioid legislation moving through Congress.”    

Earlier this week, the House separately approved two key AHA-supported bills that would allow states to receive federal matching funds for up to 30 days per year for services provided to adult Medicaid beneficiaries for opioid and cocaine use disorder in an Institution for Mental Disease, and expand treatment coverage to individuals suffering from cocaine use disorder; and align 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act to allow health care providers to responsibly share substance use disorder treatment information. 

The White House has expressed support for all three bills. The Senate is expected to consider opioid legislation as early as mid-July. 
 

Related News Articles

Headline
AHA urges smarter AI regulation for advancing innovation, safety and access to health care
The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial…
Chairperson's File
Chair File: Inside the Shutdown and Other Key 2025 Priorities
Public
This week brings the fourth week of the federal government shutdown as Congress has yet to pass legislation to fund the government. This shutdown is a bit…
Headline
Shutdown continues with no significant progress toward funding deal
The government shutdown is expected to continue into next week as the Senate is expected to adjourn Oct. 23 with no plans to vote this weekend. The chamber Oct…
Headline
Government funding bill fails 10th time in Senate as chamber adjourns until next week
The Senate Oct. 16 failed for a 10th time to advance the continuing resolution to extend government funding and end the ongoing shutdown. The chamber adjourned…
Chairperson's File
Chair File: Leadership Dialogue — Legislative Outlook and Health Care Advocacy with AHA Executive Vice President Stacey Hughes
Public
There is a saying that is very timely for our field: A smooth sea never made a skilled sailor. As we head into the final months of 2025, hospitals and health…
Headline
More Senate activity expected this week as shutdown enters third week; no formal negotiations occurring
The Senate returned to Capitol Hill today and is scheduled to hold its eighth vote on the House-passed continuing resolution, but is expected to fall short of…